Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
SummaryHighlights of the 2010 recommendations include
1) a recommendation that annual vaccination be administered to all persons aged ≥6 months for the 2010--11 influenza season; 2) a recommendation that children aged 6 months--8 years whose vaccination status is unknown or who have never received seasonal influenza vaccine before (or who received seasonal vaccine for the first time in 2009--10 but received only 1 dose in their first year of vaccination) as well as children who did not receive at least 1 dose of an influenza A (H1N1) 2009 monovalent vaccine regardless of previous influenza vaccine history should receive 2 doses of a 2010--11 seasonal influenza vaccine (minimum interval: 4 weeks) during the 2010--11 season; 3) a recommendation that vaccines containing the 2010--11 trivalent vaccine virus strains A/California/7/2009 (H1N1)-like (the same strain as was used for 2009 H1N1 monovalent vaccines), A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens be used; 4) information about Fluzone High-Dose, a newly approved vaccine for persons aged ≥65 years; and 5) information about other standard-dose newly approved influenza vaccines and previously approved vaccines with expanded age indications.Vaccination efforts should begin as soon as the 2010--11 seasonal influenza vaccine is available and continue through the influenza season. These recommendations also include a summary of safety data for U.S.-licensed influenza vaccines.These recommendations and other information are available at CDC's influenza website (http://www.cdc.gov/flu); any updates or supplements that might be required during the 2010--11 influenza season also will be available at this website. Recommendations for influenza diagnosis and antiviral use will be published before the start of the 2010--11 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information.BOX. Summary of influenza vaccination recommendations, 2010
All persons aged ≥6 months should be vaccinated annually.
Protection of persons at higher risk for influenza-related complications should continue to be a focus of vaccination efforts as providers and programs transition to routine vaccination of all persons aged ≥6 months.
When vaccine supply is limited, vaccination efforts should focus on delivering vaccination to persons who:
are aged 6 months--4 years (59 months);
are aged ≥50 years;
have chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, neurologic, hematologic, or metabolic disorders (including diabetes mellitus);
are immunosuppressed (including immunosuppression caused by medications or by human immunodeficiency virus);
are or will be pregnant during the influenza season;
are aged 6 months--18 years and receiving long-term aspirin therapy and who therefore might be at risk for experiencing Reye syndrome after influenza virus infection;
are residents of nursing homes and other chronic-care facilities;
are American Indians/Alaska Natives;
are morbidly obese (body-mass index ≥40);
are health-care personnel;
are household contacts and caregivers of children aged <5 years and adults aged ≥50 years, with particular emphasis on vaccinating contacts of children aged <6 months; and
are household contacts and caregivers of persons with medical conditions that put them at higher risk for severe complications from influenza.
All persons aged ≥6 months should be vaccinated annually.
Protection of persons at higher risk for influenza-related complications should continue to be a focus of vaccination efforts as providers and programs transition to routine vaccination of all persons aged ≥6 months.
When vaccine supply is limited, vaccination efforts should focus on delivering vaccination to persons who:
are aged 6 months--4 years (59 months);
are aged ≥50 years;
have chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, neurologic, hematologic, or metabolic disorders (including diabetes mellitus);
are immunosuppressed (including immunosuppression caused by medications or by human immunodeficiency virus);
are or will be pregnant during the influenza season;
are aged 6 months--18 years and receiving long-term aspirin therapy and who therefore might be at risk for experiencing Reye syndrome after influenza virus infection;
are residents of nursing homes and other chronic-care facilities;
are American Indians/Alaska Natives;
are morbidly obese (body-mass index ≥40);
are health-care personnel;
are household contacts and caregivers of children aged <5 years and adults aged ≥50 years, with particular emphasis on vaccinating contacts of children aged <6 months; and
are household contacts and caregivers of persons with medical conditions that put them at higher risk for severe complications from influenza.
July 29, 2010 / 59(Early Release);1-62 [Free full-text online]
No hay comentarios:
Publicar un comentario